Seido Capital

Seido Capital is an active venture capital firm specializing in early-stage investments in the life sciences sector, with a strong focus on companies leveraging artificial intelligence, biopharma, diagnostics, and digital health. The firm has a decades-long track record originating from Belgium (as Theodorus) and is now based in Montreal, Canada, with a fund performance history that places it in the top quartile/decile among VCs in the sector. Recent exits include high-value transactions such as CluePoints. Seido Capital supports companies from pre-seed through Series B and aims to accelerate transformative healthcare innovations across North America.[1][3][5][6]